Back to Search Start Over

The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)

Authors :
Mike Stedman
Rustam Rea
Christopher J. Duff
Mark Livingston
Katie McLoughlin
Louise Wong
Stephen Brown
Katherine Grady
Roger Gadsby
John M. Gibson
Angela Paisley
Anthony A. Fryer
Adrian H. Heald
Source :
Stedman, M, Rea, R, Duff, C J, Livingston, M, McLoughlin, K, Wong, L, Brown, S, Grady, K, Gadsby, R, Gibson, J M, Paisley, A, Fryer, A A & Heald, A H 2022, ' The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM) ', Endocrinology, diabetes & metabolism, vol. 5, no. 2, e00302 . https://doi.org/10.1002/edm2.302
Publication Year :
2021
Publisher :
Wiley, 2021.

Abstract

BACKGROUND: Finger prick blood glucose (BG) monitoring remains a mainstay of management in people with type 2 diabetes (T2DM) who take sulphonylurea (SU) drugs or insulin. We recently examined patient experience of BG monitoring in people with type 1 diabetes (T1DM). There has not been any recent comprehensive assessment of the performance of BG monitoring strips or the patient experience of BG strips in people with T2DM in the UK.METHODS: An online self-reported questionnaire containing 44 questions, prepared following consultation with clinicians and patients, was circulated to people with T2DM. 186 responders provided completed responses (25.5% return rate). Fixed responses were coded numerically (eg not confident = 0 fairly confident = 1).RESULTS: Of responders, 84% were treated with insulin in addition to other agents. 75% reported having had an HbA1c check in the previous 6 months. For those with reported HbA1c ≥ 65 mmol/mol, a majority of people (70%) were concerned or really concerned about the shorter term consequences of running a high HbA1c This contrasted with those who did not know their recent HbA1c, of whom only 33% were concerned/really concerned and those with HbA1c CONCLUSION: The group surveyed comprised engaged people with T2DM but even within this group there was significant variation in (a) awareness of shorter term risks, (b) confidence in their ability to implement appropriate insulin dosage (c) awareness of the limitations of BG monitoring technology. There is clearly an area where changes in education/support would benefit many.

Details

ISSN :
23989238
Volume :
5
Database :
OpenAIRE
Journal :
Endocrinology, Diabetes & Metabolism
Accession number :
edsair.doi.dedup.....27255d95598bacfef9e986caefd48745
Full Text :
https://doi.org/10.1002/edm2.302